FindTrial
Sign In

Transareolar single-port thoracoscopic lung resection for non-small cell lung cancer

Transareolar single-port thoracoscopic lung resection for non-small cell lung cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083283
Enrollment
Unknown
Registered
2024-04-19
Start date
2024-04-27
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Group1:Single-Port Thoracoscopy via the Areolar Approach Group
Group2:Single-Port Thoracoscopy via the Conventional Approach Group

Sponsors

Yantai Yuhuangding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 years. 2.American Society of Anesthesiologists score I – III. 3.No distant metastasis on preoperative examination. 4.No history of malignant tumors. 5.Not received neoadjuvant therapy.

Exclusion criteria

Exclusion criteria: 1.Did not achieve R0 resection. 2.Conversion to thoracotomy. 3.Pathologically confirmed non-NSCLC. 4.Postoperative pathology confirms distant metastasis. 5.Concurrent malignant tumors in other organs.

Design outcomes

Primary

MeasureTime frame
Overall Survival(OS);postoperative pain score;Postoperative complications;Disease-Free Survival(DFS);—

Secondary

MeasureTime frame
Surgical Time;Blood Loss;Extubation Time Postoperatively;Patient Postoperative Satisfaction;—

Countries

China

Contacts

Public ContactJian Fang;Xiaofeng Yu

Yantai Yuhuangding Hospital

fj_xwk@hotmail.com+86 186 6002 9561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026